SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Modelling the Cost Effectiveness of Lamivudine/Zidovudine Combination Therapy in HIV Infection
1 references·5 citing·20 second hop
Modelling the Cost Effectiveness of Lamivudine/Zidovudine Combination Therapy in HIV Infection (1997)Modelling the Cost Effectiveness of Lamiv…The Markov Process in Medical Prognosis (1983)The Markov Process in Medical…Comparison of Markov Model and Discrete-Event Simulation Techniques for HIV (2009)Comparison of Markov Model an…The Cost of HIV Treatment and Care (2001)The Cost of HIV Treatment and…Selecting Treatments: A Decision Theoretic Approach (2000)Selecting Treatments: A Decis…Cost Effectiveness of Combination HIV Therapy (2000)Cost Effectiveness of Combina…The use of meta-analysis in economic evaluation (1999)The use of meta-analysis in e…The file drawer problem and tolerance for null results. (1979)Meta-analysis in clinical trials (1986)Bias in meta-analysis detected by a simple, graphical test (1997)Methods for the economic evaluation of health care programmes (1987)EuroQol - a new facility for the measurement of health-related quality of life (1990)Cost-Effectiveness in Health and Medicine (1996)The Distinction Between Cost and Charges (1982)The friction cost method for measuring indirect costs of disease (1995)Economic impact of HIV/AIDS: a systematic review in five European countries (2014)Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation: Report of the ISPOR Task Force on Good Research Practices—Modeling Studies (2003)Good Practice Guidelines for Decision-Analytic Modelling in Health Technology Assessment (2006)Recent Developments in Decision-Analytic Modelling for Economic Evaluation (2006)On the Use of Markov Models in Pharmacoeconomics: Pros and Cons and Implications for Policy Makers (2020)XXIV. On the nature of the function expressive of the law of human mortality, and on a new mode of determining the value of life contingencies. In a letter to Francis Baily, Esq. F. R. S. &c (1825)A Population Study. (1975)A convenient approximation of life expectancy (the “DEALE”) (1982)The Beaver Dam Health Outcomes study (1993)Decision Making in Health and Medicine: Integrating Evidence and Values (2001)State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3 (2012)Applications of the Medical Outcomes Study health-related quality of life measures in HIV/AIDS (1997)
this work references cited by second hop

References

  • 1983The Markov Process in Medical Prognosis957 cited

Cited by

  • 2001The Cost of HIV Treatment and Care74 cited
  • 2009Comparison of Markov Model and Discrete-Event Simulation Techniques for HIV69 cited
  • 2000Cost Effectiveness of Combination HIV Therapy67 cited
  • 2000Selecting Treatments: A Decision Theoretic Approach59 cited
  • 1999The use of meta-analysis in economic evaluation9 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work